Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€225.50

€225.50

-8.700%
-21.5
-8.700%
€310.00
 
10:09 / Tradegate WKN: 716560 / Symbol: SARTF / Name: Sartorius / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Description Sartorius

Sartorius is a German company that specializes in providing cutting-edge laboratory and process technologies and equipment to the biopharmaceutical industry. The company was founded in 1870 and has its headquarters in Göttingen, Germany.

Sartorius operates through two divisions: Bioprocess Solutions and Lab Products Services. Bioprocess Solutions develops and produces instruments, equipment, and consumables for the entire biopharmaceutical production process from lab to production scale, while Lab Products Services supplies laboratory instruments, consumables, and services to customers.

The company’s products are used in a wide range of areas such as cell culture, fermentation, filtration, purification, and laboratory weighing, among others. Sartorius also offers a broad range of services to help customers optimize their workflows, enhance their product quality, and comply with regulatory requirements.

Sartorius has a strong global presence and sells its products in more than 110 countries. It has offices and production sites in Europe, North and South America, Asia, and Australia. The company is traded on the Frankfurt Stock Exchange under the symbol SARTF, and its market cap is currently around €37 billion.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Sartorius AG ST is only available for our menbers.
Not a member yet? Sign up for free!

Competitors of Sartorius

Sartorius AG is a leading German laboratory and pharmaceutical equipment provider with a variety of operating segments, including bioprocess solutions, lab products and services, and industrial weighing. As a result of its diverse operations, the company has multiple competitors across various segments. Here are some of the most notable competitors of Sartorius:

1. Thermo Fisher Scientific: Thermo Fisher Scientific is an American company focused on providing scientific research products and services. The company offers technologies such as instruments, reagents, software and services to support academic and pharmaceutical and biotech companies.

2. Danaher Corporation: Danaher Corporation is an American company that produces industrial and consumer products. The company's most well-known brand includes Beckman Coulter.

3. Agilent Technologies: Agilent Technologies is a global scientific instruments company headquartered in California. The company provides analytical instruments, software and services to the life sciences, diagnostics and applied chemical markets.

4. PerkinElmer: PerkinElmer is a global leader in providing products and services in the fields of diagnostics and applied chemical markets.

5. Eppendorf: Eppendorf is a German life science equipment company that develops, manufactures and distributes scientific instruments such as pipettes, centrifuges, and consumables.

Overall, these companies form a competitive environment for Sartorius, each operating in various niches within the broader industry.

Suppliers of Sartorius

Sartorius is a German-based company that primarily offers laboratory and biopharmaceutical products and services. As such, their most important suppliers are likely to be other companies that provide raw materials or components for their products.

Some potential key suppliers for Sartorius might include:

1. Pharmaceutical and biotech suppliers: Since Sartorius primarily serves customers in the life science and healthcare industries, they may rely on suppliers of chemicals, reagents, and other raw materials for drug development and production.

2. Electronic and mechanical component manufacturers: Sartorius also produces a range of laboratory instruments and equipment that may require specialized components like sensors, motors, or circuit boards.

3. Material handling and logistics providers: Depending on their supply chain and distribution channels, Sartorius may need to work with suppliers of packaging materials, shipping and logistics providers, or warehousing and distribution partners.

4. Service providers and specialized contractors: Lastly, Sartorius may also contract with service providers like contract research organizations (CROs), lab services companies, or engineering firms for specialized projects or maintenance needs.

Financial data and news for Sartorius

sharewise wants to provide you with the best news and tools for Sartorius, so we directly link to the best financial data sources.

News

EQS-News: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
EQS-News: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
EQS-News: Resolutions of the Annual General Meeting of Sartorius AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: Resolutions of the Annual General Meeting of Sartorius AG
EQS-News: Resolutions of the Annual General Meeting of Sartorius AG
EQS-News: Sartorius releases Annual Report for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: Sartorius releases Annual Report for 2023
EQS-News: Sartorius releases Annual Report for 2023
EQS-News: The Supervisory Board of Sartorius AG proposes  a dividend of 0.74 euros per preference share: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share
EQS-News: The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share
EQS-Adhoc: SARTORIUS AG: Sartorius successfully completes placement of 200 million euros of treasury preference shares: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-Adhoc: SARTORIUS AG: Sartorius successfully completes placement of 200 million euros of treasury preference shares
EQS-Adhoc: SARTORIUS AG: Sartorius successfully completes placement of 200 million euros of treasury preference shares
EQS-Adhoc: SARTORIUS AG: Sartorius launches placement of up to 200 million euros of treasury preference shares through accelerated bookbuilding : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-Adhoc: SARTORIUS AG: Sartorius launches placement of up to 200 million euros of treasury preference shares through accelerated bookbuilding
EQS-Adhoc: SARTORIUS AG: Sartorius launches placement of up to 200 million euros of treasury preference shares through accelerated bookbuilding
EQS-News: Sartorius expects profitable growth in 2024; double-digit annual sales revenue growth projected through to 2028: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: Sartorius expects profitable growth in 2024; double-digit annual sales revenue growth projected through to 2028
EQS-News: Sartorius expects profitable growth in 2024; double-digit annual sales revenue growth projected through to 2028
EQS-News: SARTORIUS AG: Sartorius nine-month figures: Normalization of demand continues after end of pandemic: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: SARTORIUS AG: Sartorius nine-month figures: Normalization of demand continues after end of pandemic
EQS-News: SARTORIUS AG: Sartorius nine-month figures: Normalization of demand continues after end of pandemic